Valuation: Haemonetics Corporation

Market Cap 3.38B 2.96B 2.73B 2.52B 4.75B 325B 4.84B 32.58B 12.78B 159B 12.7B 12.42B 548B P/E 2027 *
18.9x
P/E 2028 * 16.7x
Enterprise Value 4.05B 3.54B 3.28B 3.03B 5.7B 389B 5.8B 39.06B 15.32B 191B 15.23B 14.89B 657B EV / Sales 2027 *
2.89x
EV / Sales 2028 * 2.55x
Free-Float
98.78%
Yield 2027 *
2.69%
Yield 2028 * -
1 day-3.23%
1 week-0.63%
Current month-0.79%
1 month-4.85%
3 months+23.03%
6 months-1.74%
Current year-7.16%
1 week 71.81
Extreme 71.81
77.75
1 month 71.81
Extreme 71.81
79.82
Current year 51
Extreme 51
86.11
1 year 47.32
Extreme 47.315
87.32
3 years 47.32
Extreme 47.315
97.97
5 years 43.5
Extreme 43.5
97.97
10 years 29.17
Extreme 29.17
142.11
Manager TitleAgeSince
Chief Executive Officer 62 16/05/2016
Director of Finance/CFO 55 11/04/2022
Chief Operating Officer 56 01/04/2025
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Director/Board Member 71 23/07/2014
Director/Board Member 62 16/05/2016
Date Insider Type Main position Quantity % Market Cap.
06-05Tax

VP, Chief Accounting Officer

-259 0.0006%
06-05Tax

Head of Human Resources

-313 0.0007%
05-15Tax

Executive/Senior Manager

-28,414 0.0611%
Change 5-day change 1-year change 3-year change Capi.($)
-3.23%-0.63%-2.94%-11.42% 3.38B
-3.42%-7.18%-32.62%-17.58% 155B
-5.11%-5.40%-11.62%-9.53% 102B
-1.26%-0.72%+1.76%+57.91% 58.81B
-0.94%+5.94%+39.64%+55.35% 52.82B
-2.07%-3.61%-14.93%-41.92% 41.51B
-4.73%-10.11% - - 32.69B
-2.92%+0.75%-13.14%-46.02% 28.6B
-0.57%+0.44%+59.32%-7.14% 25.27B
-3.83%-3.09%-7.56%-8.88% 20.34B
Average -1.95%-2.98%+1.99%-3.25% 51.99B
Weighted average by Cap. -1.07%-4.29%-7.59%-1.68%

Financials

2027 *2028 *
Net sales 1.4B 1.23B 1.13B 1.05B 1.97B 135B 2.01B 13.51B 5.3B 65.93B 5.27B 5.15B 227B 1.47B 1.29B 1.19B 1.1B 2.07B 142B 2.11B 14.2B 5.57B 69.34B 5.54B 5.42B 239B
Net income 176M 154M 142M 132M 248M 16.94B 252M 1.7B 667M 8.3B 663M 648M 28.56B 204M 178M 165M 152M 286M 19.58B 292M 1.96B 770M 9.59B 766M 749M 33.01B
Net Debt 672M 588M 543M 502M 945M 64.59B 962M 6.48B 2.54B 31.63B 2.53B 2.47B 109B 385M 336M 311M 287M 541M 36.96B 551M 3.71B 1.45B 18.1B 1.45B 1.41B 62.32B
Logo Haemonetics Corporation
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Employees
3,009
Date Price Change Volume
14/07/26 US$74.41 -3.23% 650,537
13/07/26 US$76.89 +0.92% 691,162
10/07/26 US$76.19 +1.59% 456,265
09/07/26 US$75.00 +1.60% 423,986
08/07/26 US$73.82 -1.42% 618,766
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
74.41USD
Average target price
86.10USD
Spread / Average Target
+15.71%

Quarterly revenue - Rate of surprise